|
Volumn 46, Issue 9, 2002, Pages 2545-2546
|
Treatment of fibromyalgia with sibutramine hydrochloride monohydrate: Comment on the article by Goldenberg et al [6] (multiple letters)
a b a c c |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMITRIPTYLINE;
BUSPIRONE;
DULOXETINE;
FENTANYL;
FLUOXETINE;
HYDROCODONE;
MILNACIPRAN;
PARACETAMOL;
PREDNISONE;
SIBUTRAMINE;
VENLAFAXINE;
ZOLPIDEM;
ADULT;
AGED;
ANTICHOLINERGIC EFFECT;
AUTONOMIC DYSFUNCTION;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FATIGUE;
FEMALE;
FIBROMYALGIA;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
ORTHOSTATIC HYPOTENSION;
PAIN;
PHYSICAL CAPACITY;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SEDATION;
SEROTONIN SYNDROME;
SIDE EFFECT;
TREATMENT OUTCOME;
VISUAL ANALOG SCALE;
|
EID: 0036744980
PISSN: 00043591
EISSN: None
Source Type: Journal
DOI: 10.1002/art.10642 Document Type: Letter |
Times cited : (12)
|
References (0)
|